|
| Pronunciation |
 (loe
SAR tan & hye droe klor oh
THYE a zide) |
 |
| U.S. Brand Names |
| Hyzaar® |
|
| Generic Available |
|
No |
|
| Synonyms |
| Hydrochlorothiazide and Losartan |
|
| Pharmacological Index |
|
Antihypertensive Agent, Combination |
|
| Use |
|
Treatment of hypertension |
|
| Pregnancy Risk Factor |
|
C/D (2nd and 3rd trimesters) |
|
| Usual Dosage |
|
Adults: Oral: 1 tablet daily |
|
| Cardiovascular Considerations |
|
Combination therapy for the treatment of hypertension should be individualized for each patient. Potential advantages for losartan and hydrochlorothiazide combination therapy may include improved compliance and synergistic reductions in blood pressure with an accompanied reduction in side effects. |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed. |
|
| Dosage Forms |
|
Tablet: Losartan potassium 50 mg and hydrochlorothiazide 12.5 mg; losartan potassium 100 mg and hydrochlorothiazide 25 mg |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
